This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Advisory Board (ABCO) in Focus: Stock Moves 6.4% Higher
by Zacks Equity Research
Advisory Board (ABCO) shares rose more than 6% in the last trading session, amid huge volumes.
Why Biotelemetry (BEAT) Could Be an Impressive Growth Stock
by Zacks Equity Research
Biotelemetry (BEAT) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.
The Zacks Analyst Blog Highlights: Health Insurance Innovations, BioTelemetry, Solaredge Technologies, Aaron's and Petmed Express
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Health Insurance Innovations, BioTelemetry, Solaredge Technologies, Aaron's and Petmed Express
Here's Why Investors Should Buy BioTelemetry (BEAT) Now
by Zacks Equity Research
BioTelemetry's (BEAT) buyout of LifeWatch AG has expanded its product portfolio and customer base in the cardiac monitoring and diagnostic services space.
BioTelemetry Hits a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
BioTelemetry (BEAT) is putting efforts in product innovation through research and development. The company recently announced the acquisition of LifeWatch AG in a deal valued at about $280 million.
New Strong Buy Stocks for August 16th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
Top Ranked Momentum Stocks to Buy for August 16th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 16th:
BioTelemetry (BEAT) Q2 Earnings Top, Revenues Meet Estimates
by Zacks Equity Research
BioTelemetry (BEAT) rides high on all its segments in Q2. The company is also putting in efforts in product innovation through research and development.
BioTelemetry (BEAT) Acquires LifeWatch for $280 Million
by Zacks Equity Research
BioTelemetry Inc. (BEAT) enhances its position in the wireless medicine space, enlarges product profile and customer base in cardiac monitoring and diagnostic services with LifeWatch buyout.
BioTelemetry, Inc. (BEAT) in Focus: Stock Moves 6.5% Higher
by Zacks Equity Research
BioTelemetry (BEAT) was a big mover last session, as the company saw its rise nearly 7% on Friday amid huge volumes.
Will BioTelemetry (BEAT) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in BioTelemetry, Inc. (BEAT).
BioTelemetry (BEAT) Shows Strength: Stock Moves 8.8% Higher
by Zacks Equity Research
BioTelemetry, Inc. (BEAT) shares rose almost 9% in the last trading session.
This Week's Hidden Gems: (AAOI)(BEAT)
by Patrick Anderson
Tracey Ryniec uncovers two top stocks that are flying under the radar.
Teladoc Continues to Grow in Booming Telehealth Industry
by Zacks Equity Research
Teladoc Inc. (TDOC), a premier telehealth services provider, is rapidly expanding its business in the booming telehealth services industry.
The Zacks Analyst Blog Highlights: BioTelemetry, WellCare Health Plans, Joint, HCA Holdings and Chemed
by Zacks Equity Research
The Zacks Analyst Blog Highlights: BioTelemetry, WellCare Health Plans, Joint, HCA Holdings and Chemed
5 Stocks to Buy for the Post-Obamacare Era
by Swarup Gupta
Insurers, hospitals and healthcare service providers with strong fundamentals would make welcome additions to your portfolio.
BioTelemetry (BEAT) Looks Good: Stock Adds 7.2% in Session
by Zacks Equity Research
BioTelemetry, Inc. (BEAT) saw its shares rise above 7% in the last trading session.
New Strong Buy Stocks for February 24th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
New Strong Buy Stocks for August 11th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
New Strong Buy Stocks for August 9th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
5 Strong Stocks in Stronger Industries
by David Bartosiak
The market rewards strength. These are the best stocks in the best industries.
Top 5 Medical Service Stocks to Buy
by Brian Hamilton
The Medical sector is one of the top performing sectors for Q3 2015, and it is expected to be a top performer in Q4 2015 too.
Two Perfectly Timed Momentum Stock Trades
by David Bartosiak
These two stock ideas are showing up at the perfect time to buy.
5 Top Performing Stocks to Buy
by David Bartosiak
If a stock can perform in this market, imagine how it will do when things normal out